If you see particles, cloudiness, or discoloration, dont use it
Accountability To provide support and accountability, one of our wellness coaches will meet with you via video each week
A new oral weight loss medication, Foundayo (Orforglipron) by Eli Lilly and Company, has recently gained attention as a promising option for adults struggling with obesity and overweight-related health conditions
The patients were randomized 2:1:1 to receive subcutaneous injection of WEGOVY 2.4 mg, WEGOVY 1.7 mg, or placebo
SEMAGLUTIDE AND PROGRESSION TO ESKD As CKD advances, patients are at increasing risk of requiring kidney replacement therapy
Diarrhoea and vomiting would reduce absorption of food and this could have impacted weight loss